Black Diamond Therapeutics
BDTX
BDTX
93 hedge funds and large institutions have $95.8M invested in Black Diamond Therapeutics in 2025 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 27 increasing their positions, 17 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
93
Holders Change
+9
Holders Change %
+10.71%
% of All Funds
1.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
36
Increased
27
Reduced
17
Closed
27
Calls
$61K
Puts
$9K
Net Calls
+$52K
Net Calls Change
-$35K
Top Buyers
| 1 |
Marshall Wace
London,
United Kingdom
|
+$1.83M |
| 2 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$821K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$595K |
| 4 |
Jane Street
New York
|
+$517K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$461K |
Top Sellers
| 1 |
BlackRock
New York
|
-$5.91M |
| 2 |
NL
Nuveen LLC
Charlotte,
North Carolina
|
-$3.33M |
| 3 |
State Street
Boston,
Massachusetts
|
-$1.62M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.17M |
| 5 |
Morgan Stanley
New York
|
-$828K |
